Stock Taper
SCREENER COMPARE ANY 2 STOCKS
IMTX
IMMATICS N.V.
NASDAQ
$9.45
▲ UP 0.96% (0.09)

KEY STATISTICS

Market Cap$1.27 B
52w High$12.41
52w Low$5.05
Dividend Yield—
Frequency—
P/E-5.08
Volume1.09M
Shares Out.134.10M

COMPANY

LEADERSHIP

Harpreet Singh
CHIEF EXECUTIVE
Harpreet Singh

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 12, 2018
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
678

PRICE TARGET

Target High$17.00
Target Low$17.00
Target Median$17.00
Target Consensus$17.00

UPCOMING EARNINGS

DateNov 17, 2026
DayTuesday
Rev. Est.$12.67M
NOV
17
TUE

PRICE

$9.45 ▲ UP 0.96% (+$0.09)
$9.40$9.60$9.809:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM9.45

About Immatics N.V.

https://www.immatics.com ↗

Immatics N.V. is a clinical-stage biopharmaceutical company developing TCR-based immunotherapies, including adoptive cell therapies and bispecifics, for solid tumors, with collaborations worldwide.

INDUSTRY

Biotechnology

A PRODUCT IMMATICS N.V. IS KNOWN FOR

anzu-cel (IMA203)
anzu-cel (IMA203)

Anzu-cel is Immatics' leading T-cell therapy targeting PRAME, in Phase 3 for melanoma, representing the company's primary focus and near-term commercial potential.

COMPETITORS

COMPETITOR
BNTX COMPARE
CRSP COMPARE
IOVA COMPARE
TCRX COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
9
LISTED HERE
6
RANKED BY POSITION SIZE
SPDW
0.00% · 195.0K
CANC
0.80% · 179.6K
SBIO
0.65% · 165.4K
ONEQ
0.01% · 60.8K
BBC
0.60% · 33.4K
RFLR
0.06% · 5.5K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
72.64%
HOLDERS
105
TOP 12 OF 105 · RANKED BY POSITION SIZE
T. Rowe Price Investment Management, Inc.
21.7M sh · $213.06M
Rtw Investments, LP
12.9M sh · $126.63M
Baker Bros. Advisors LP
12.1M sh · $126.99M
Suvretta Capital Management, LLC
12.0M sh · $102.5M
Perceptive Advisors LLC
10.4M sh · $102.17M
Toronto Dominion Bank
7.4M sh · $73.17M
Vestal Point Capital, LP
6.3M sh · $54.1M
Jefferies Financial Group Inc.
5.1M sh · $49.79M
Sofinnova Investments, Inc.
3.6M sh · $35.72M
Morgan Stanley
2.2M sh · $18.79M
Citadel Advisors LLC
1.9M sh · $18.22M
Woodline Partners LP
1.8M sh · $15.69M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book2
Overall Score2

INSIDER TRADES

★
DIRECTOR
PERCEPTIVE ADVISORS LLC
Purchase · 863.1K shares
2026-08-26
★
OFFICER: GEN COUNSEL AND CORP SECRETARY
Pepin James Nelson
Purchase · 181.2K shares
2026-08-14
★
OFFICER: GEN COUNSEL AND CORP SECRETARY
Pepin James Nelson
Purchase · 43.8K shares
2026-08-14
★
OFFICER
Pepin James Nelson
— · —
2026-07-20

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
OUTPERFORM 1
3 GRADES IN THE LAST 12 MONTHS
Chardan Capital BUY Mizuho OUTPERFORM Guggenheim BUY

SECTORS PEERS

PEERPRICE
ELVN$57.86COMPARE
RLAY$18.77COMPARE
ATAI$7.29COMPARE
PGEN$6.95COMPARE
NKTR$72.52COMPARE
INBX$123.41COMPARE
SNDX$19.54COMPARE